|
1.
|
P CorreaHuman gastric carcinogenesis: a
multistep and multifactorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and PreventionCancer
Res52673567401992
|
|
2.
|
S KiechlE LorenzM ReindlToll-like receptor
4 polymorphisms and atherogenesisN Engl J
Med347185192200210.1056/NEJMoa01267312124407
|
|
3.
|
K HoshinoO TakeuchiT KawaiCutting edge:
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to
lipopolysaccharide: evidence for TLR4 as the Lps gene productJ
Immunol16237493752199910201887
|
|
4.
|
S KeatesYS HittiM UptonCP
KellyHelicobacter pylori infection activates NF-kappa B in
gastric epithelial
cellsGastroenterology11310991109199710.1053/gast.1997.v113.pm9322504
|
|
5.
|
RA HatzG RiederM StoltePattern of adhesion
molecule expression on vascular endothelium in Helicobacter
pylori associated antral
gastritisGastroenterology11219081919199710.1053/gast.1997.v112.pm91786839178683
|
|
6.
|
S MaedaH YoshidaK OguraH. pylori
activates NF-kappaB through a signaling pathway involving IkappaB
kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric
cancer cellsGastroenterology11997108200010.1053/gast.2000.8540
|
|
7.
|
MG SmithGL HoldE TaharaEM El-OmarCellular
and molecular aspects of gastric cancerWorld J
Gastroenterol12297929902006
|
|
8.
|
J ParsonnetGD FriedmanDP
VandersteenHelicobacter pylori infection and the risk of
gastric carcinomaN Engl J
Med32511271131199110.1056/NEJM199110173251603
|
|
9.
|
MJ BlaserJ ParsonnetParasitism by the
‘slow’ bacterium Helicobacter pylori leads to altered
gastric homeostasis and neoplasiaJ Clin Invest94481994
|
|
10.
|
JQ HuangS SridharY ChenRH
HuntMeta-analysis of the relationship between Helicobacter
pylori seropositivity and gastric
cancerGastroenterology11411691179199810.1016/S0016-5085(98)70422-69609753
|
|
11.
|
M EstellerPG CornSB BaylinJG HermanA gene
hypermethylation profile of human cancerCancer
Res6132253229200111309270
|
|
12.
|
T TaharaT ShibataM NakamuraIncreased
number of CpG island hypermethylation in tumor suppressor genes of
nonneoplastic gastric mucosa correlates with higher risk of gastric
cancerDigestion822736201010.1159/00025276620150736
|
|
13.
|
JP IssaYL OttavianoP CelanoSR HamiltonNE
DavidsonSB BaylinMethylation of the oestrogen receptor CpG island
links ageing and neoplasia in human colonNat
Genet4536540199410.1038/ng0894-5367951326
|
|
14.
|
N AhujaQ LiAL MohanSB BaylinJP IssaAging
and DNA methylation in colorectal mucosa and cancerCancer
Res235489549419989850084
|
|
15.
|
JP IssaN AhujaM ToyotaMP BronnerTA
BrentnallAccelerated age-related CpG island methylation in
ulcerative colitisCancer Res6135733577200111325821
|
|
16.
|
YS BianMC OsterheldC FontollietFT BosmanJ
Benhattarp16 inactivation by methylation of the CDKN2A promoter
occurs early during neoplastic progression in Barrett’s
esophagusGastroenterology122111311212001
|
|
17.
|
T MaekitaK NakazawaM MiharaHigh levels of
aberrant DNA methylation in Helicobacter pylori-infected
gastric mucosae and its possible association with gastric cancer
riskClin Cancer Res12989995200616467114
|
|
18.
|
T TaharaT ArisawaT SibataRisk prediction
of gastric cancer by analysis of aberrant DNA methylation in
non-neoplastic gastric
epitheliumDigestion755461200710.1159/00010177517438355
|
|
19.
|
GH KangHJ LeeKS HwangS LeeJH KimJS
KimAberrant CpG island hypermethylation of chronic gastritis, in
relation to aging, gender, intestinal metaplasia, and chronic
inflammationAm J
Pathol16315511556200310.1016/S0002-9440(10)63511-014507661
|
|
20.
|
GH KangS LeeJS LimHY JungProfile of
aberrant CpG island methylation along the multistep pathway of
gastric carcinogenesisLab
Invest83635641200310.1097/01.LAB.0000067481.08984.3F12746473
|
|
21.
|
YF ZouF WangXL FengAssociation of
NFKB1 −94ins/delATTG promoter polymorphism with
susceptibility to auto-immune and inflammatory diseases: a
meta-analysisTissue Antigens779172010
|
|
22.
|
YF ZouFL YuanXL FengAssociation between
NFKB1 −94ins/delATTG promoter polymorphism and cancer risk:
a meta-analysisCancer Invest2978852010
|
|
23.
|
T TaharaT ArisawaT ShibataIncreased number
of methylated CpG islands correlates with Helicobacter
pylori infection, histological and serological severity of
chronic gastritisEur J Gastroenterol
Hepatol21613619200910.1097/MEG.0b013e32830e28b219307977
|
|
24.
|
T TaharaT ShibataT ArisawaImpact of
catechol-O-methyltransferase (COMT) gene polymorphism on promoter
methylation status in gastric mucosaAnticancer
Res2928572861200919596974
|
|
25.
|
T ArisawaT TaharaT ShibataThe relationship
between Helicobacter pylori infection and promoter
polymorphism of the Nrf2 gene in chronic gastritisInt J Mol
Med191431482007
|
|
26.
|
H ShiroedaT TaharaT ShibataFunctional
promoter polymorphisms of macrophage migration inhibitory factor
(MIF) in peptic ulcer diseasesInt J Mol Med26707711201020878093
|
|
27.
|
MF DixonRM GentaJH YardleyP
CorreaClassification and grading of gastritis: the updated Sydney
systemAm J Surg
Pathol2011611181199610.1097/00000478-199610000-000018827022
|
|
28.
|
AS KarbanT OkazakiCI PanhuysenFunctional
annotation of a novel NFKB1 promoter polymorphism that
increases risk for ulcerative colitisHum Mol
Genet133545200414613970
|
|
29.
|
H LiL GaoZ ShenAssociation study of
NFKB1 and SUMO4 polymorphisms in Chinese patients with
psoriasis vulgarisArch Dermatol Res3004254332008
|
|
30.
|
SS LoJH ChenCW WuWY LuiFunctional
polymorphism of NFKB1 promoter may correlate to the
susceptibility of gastric cancer in aged
patientsSurgery1452802852009
|
|
31.
|
Y HeH ZhangJ YinIκBα gene promoter
polymorphisms are associated with hepatocarcinogenesis in patients
infected with hepatitis B virus genotype
CCarcinogenesis30191619222009
|
|
32.
|
A KurylowiczY HiromatsuB
Jurecka-LubienieckaAssociation of NFKB1 −94ins/del ATTG
promoter polymorphism with susceptibility to and phenotype of
Graves’ diseaseGenes Immun85325382007
|
|
33.
|
V AndersenJ ChristensenK OvervadA
TjønnelandU VogelPolymorphisms in NFκB, PXR, LXR and risk of
colorectal cancer in a prospective study of DanesBMC
Cancer104842010
|
|
34.
|
A MartínezE SánchezA ValdiviaEpistatic
interaction between FCRL3 and NFkappaB1 genes in Spanish patients
with rheumatoid arthritisAnn Rheum Dis6511881191200616476711
|
|
35.
|
MM MirzaSA FisherC OnnieNo association of
the NFKB1 promoter polymorphism with ulcerative colitis in a
British case control cohortGut5412051206200516009698
|
|
36.
|
J GlasHP TörökL TonenchiRole of the
NFKB1 −94ins/delATTG promoter polymorphism in IBD and
potential interactions with polymorphisms in the CARD15/NOD2, IKBL,
and IL-1RN genesInflamm Bowel Dis126066112006
|
|
37.
|
EK BajwaPC CremerMN GongAn NFKB1
promoter insertion/deletion polymorphism influences risk and
outcome in acute respiratory distress syndrome among CaucasiansPLoS
One6e19469201121573030
|
|
38.
|
SG PereiraF OakleyNuclear factor-kappaB1:
regulation and functionInt J Biochem Cell
Biol4014251430200810.1016/j.biocel.2007.05.00417693123
|
|
39.
|
MP de WintherE KantersG KraalMH
HofkerNuclear factor kappaB signaling in atherogenesisArterioscler
Thromb Vasc Biol25904914200515731497
|
|
40.
|
L LinGN DeMartinoWC GreeneCotranslational
biogenesis of NF-kappaB p50 by the 26S
proteasomeCell92819828199810.1016/S0092-8674(00)81409-99529257
|
|
41.
|
ND PerkinsIntegrating cell-signalling
pathways with NF-kappaB and IKK functionNat Rev Mol Cell
Biol84962200710.1038/nrm208317183360
|
|
42.
|
MS HaydenS GhoshShared principles in
NF-kappaB
signalingCell132344362200810.1016/j.cell.2008.01.02018267068
|
|
43.
|
M GadjevaMF TomczakM ZhangA role for
NF-kappaB subunits p50 and p65 in the inhibition of
lipopolysaccharide-induced shockJ
Immunol17357865793200410.4049/jimmunol.173.9.578615494531
|
|
44.
|
W HanM JooMB EverhartMyeloid cells control
termination of lung inflammation through the NF-kappaB pathwayAm J
Physiol Lung Cell Mol
Physiol296L320L327200910.1152/ajplung.90485.200819098124
|
